Pulse Biosciences is exploding higher today, recovering from earlier volatility that saw the stock experience both overnight declines and a 7.3 percent pullback in recent sessions. The primary catalyst for this upward momentum is a new analyst initiation from Freedom Capital, which launched coverage on the company with a Buy rating and a price target of 73.00. This positive sentiment appears to have successfully countered the broader sector headwinds observed earlier this week, when healthcare stocks faced downward pressure and led market losses.